Teladoc Health (NYSE:TDOC) Reaches New 1-Year Low on Analyst Downgrade

Teladoc Health, Inc. (NYSE:TDOC) shares hit a new 52-week low during mid-day trading on Monday after Jefferies Financial Group lowered their price target on the stock from $10.00 to $8.00. Jefferies Financial Group currently has a hold rating on the stock. Teladoc Health traded as low as $6.38 and last traded at $6.45, with a volume of 2474952 shares changing hands. The stock had previously closed at $6.83.

Several other analysts have also recently weighed in on TDOC. Oppenheimer lowered their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group lowered their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Bank of America dropped their target price on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating for the company in a research report on Friday, April 11th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $10.82.

Insider Buying and Selling at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.95% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently made changes to their positions in TDOC. Geode Capital Management LLC lifted its stake in Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after acquiring an additional 56,864 shares during the period. Versant Capital Management Inc lifted its position in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares during the period. Smith Anglin Financial LLC purchased a new stake in shares of Teladoc Health in the 4th quarter worth about $108,000. Arkadios Wealth Advisors purchased a new position in shares of Teladoc Health during the fourth quarter valued at about $115,000. Finally, Nisa Investment Advisors LLC raised its stake in Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after buying an additional 424,180 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Up 6.1 %

The company’s fifty day simple moving average is $8.92 and its 200 day simple moving average is $9.60. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.21 billion, a PE ratio of -1.20 and a beta of 1.73.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.